Search Results - "Yenson, Paul"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Predictors of attempted inferior vena cava filters retrieval in a tertiary care centre by Peterson, Erica A, Yenson, Paul R, Liu, Dave, Lee, Agnes Y.Y

    Published in Thrombosis research (01-08-2014)
    “…Abstract Background Retrieval rates of optional recovery inferior vena cava (IVC) filters in US hospitals range from 11 - 70%. We conducted a retrospective…”
    Get full text
    Journal Article
  5. 5

    Solvent-Detergent Plasma for the Treatment of Thrombotic Microangiopathies: A Canadian Tertiary Care Centre Experience by Lee, Lauren J., Roland, Kristine J., Sreenivasan, Gayatri M., Zypchen, Leslie N., Ambler, Kimberley L.S., Yenson, Paul R.

    Published in Transfusion and apheresis science (01-04-2018)
    “…Solvent detergent-treated plasma (SDP) is a pathogen-inactivated blood plasma, which in comparison to frozen plasma is associated with lower rates of allergic…”
    Get full text
    Journal Article
  6. 6

    A series of 4 cases of distinct keratopathy secondary to dysproteinemia: Immunotactoid keratopathy by Hall, Riley B., BSc, MD, Yeung, Sonia N., MD, PhD, FRCSC, Yenson, Paul R., MD, FRCPC, Moloney, Gregory, MBBS, MMed, FRANZCO, FRCSC

    Published in Canadian journal of ophthalmology (01-08-2014)
    “…Abstract Objective To describe a series of 4 cases of immunotactoid keratopathy (ITK) secondary to monoclonal gammopathy. Design Multicentre retrospective case…”
    Get full text
    Journal Article
  7. 7

    Azathioprine‐associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S‐methyltransferase deficiency by Yenson, Paul R., Forrest, Donna, Schmiegelow, Kjell, Dalal, Bakul I.

    Published in American journal of hematology (01-01-2008)
    “…Immunosuppressive thiopurines like azathioprine, 6‐mercaptopurine, and thioguanine are commonly used in inflammatory and neoplastic disorders. A subset of…”
    Get full text
    Journal Article
  8. 8

    Combined neutrophil and erythrocyte agglutination in a 7-year-old boy by Yenson, Paul R, Fleming, Adam, Kaikov, Yigal, Wadsworth, Louis D

    Published in Journal of pediatric hematology/oncology (01-09-2007)
    “…Leukoagglutination is a rare in vitro phenomenon, with demonstration of both temperature and/or ethylenediaminetetraacetic acid dependence. We report a case of…”
    Get full text
    Journal Article
  9. 9

    Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline by Liu, David, Peterson, Erica, Dooner, James, Baerlocher, Mark, Zypchen, Leslie, Gagnon, Joel, Delorme, Michael, Sing, Chad Kim, Wong, Jason, Guzman, Randolph, Greenfield, Gavin, Moodley, Otto, Yenson, Paul

    “…Novel oral anticoagulants (rivaroxaban, dabigatran and apixaban) have also been shown to be effective for the treatment of acute DVT (see Appendix 2). Studies…”
    Get full text
    Journal Article
  10. 10

    Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing by Avila, Laura, Amiri, Nour, Yenson, Paul, Khan, Shirin, Zavareh, Zahra Tofighi, Chan, Anthony K.C., Williams, Suzan, Brandão, Leonardo R.

    Published in The Journal of pediatrics (01-11-2020)
    “…To determine the applicability of the 4Ts score and the Heparin-Induced Thrombocytopenia (HIT) Expert Probability (HEP) score in children with suspected HIT…”
    Get full text
    Journal Article
  11. 11

    Absence of Viral Complications When Using Rituximab to Treat TTP with Plasma Exchange by Rock, Gail, Weger, Steven, Abouhadjar, Hana, Barth, David, Clark, William, Yenson, Paul R., Foley, Stephen Ronan

    Published in Blood (03-12-2015)
    “…INTRODUCTION Rituximab is widely used for the treatment of B cell lymphoma and, increasingly, for therapy in autoimmune diseases including TTP. One of the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit by Sun, Haowei (Linda), Chan, Stella, Yenson, Paul, Jackson, Shannon

    Published in Clinical and applied thrombosis/hemostasis (01-03-2018)
    “…Inhibitor risk in nonsevere hemophilia A increases with cumulative factor VIII (FVIII) exposure days and high-risk mutations. A standardized approach to…”
    Get full text
    Journal Article
  14. 14

    Prothrombin Complex Concentrates Compared with Frozen Plasma for Urgent Reversal of Vitamin K Antagonists: A Single Centre Retrospective Review by Lee, Lauren J., Chi, Jay, Chipperfield, Kate M., Yenson, Paul R.

    Published in Blood (06-12-2014)
    “…▪ Background: Vitamin K antagonists (VKAs) are associated with a risk of major bleeding requiring urgent reversal with frozen plasma (FP) or prothrombin…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Prospective Study of an Inferior Vena Cava Filter Management Pathway in a Tertiary Care and Trauma Centre by Peterson, Erica A., Yenson, Paul R., Kritzinger, Jacobus C., Lee, Lauren J., Chi, Jay, Liu, David M., Lee, Agnes Y.Y.

    Published in Blood (06-12-2014)
    “…▪ Background: In our institution, a retrospective analysis of inferior vena cava (IVC) filter usage demonstrated attempted removal in only 60% of patients. We…”
    Get full text
    Journal Article
  17. 17

    Safety and Feasibility of Red Cell Exchange for Sickle Cell Disease Across Canada by Ward, Richard, Barth, David, Couban, Stephen, Naessens, Veronique, Ritchie, Bruce, Yenson, Paul, Kuo, Kevin

    Published in Transfusion and apheresis science (01-08-2016)
    “…Abstract We outline a case whereby RBCX was successfully provided over disparate geographical areas and time zones in Canada and overcame the logistical…”
    Get full text
    Journal Article
  18. 18

    A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP by Foley, Stephen Ronan, Rock, Gail, Barth, David, Arnold, Donald M., Webert, Kathryn E, Yenson, Paul R., Kelton, John G., Clark, William Foster, Li, Lihua

    Published in Blood (06-12-2014)
    “…Background: As many as 30-50% of patients diagnosed with Thrombotic Thrombocytopenic Purpura (TTP) either relapse or become refractory to therapeutic plasma…”
    Get full text
    Journal Article
  19. 19

    Reasons for Failure to Remove Inferior Vena Cava Filters: Retrospective Study in a Tertiary Care and Trauma Centre by Peterson, Erica A., Yenson, Paul R., Liu, Dave, Lee, Andy W.J., Lee, Agnes Y.

    Published in Blood (18-11-2011)
    “…Abstract 3141 Inferior vena cava filter (IVCF) use has been rising exponentially since the introduction of percutaneous image guided IVCF placement and the…”
    Get full text
    Journal Article
  20. 20

    The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era by Savage, Kerry J., Yenson, Paul R., Shenkier, Tamara, Klasa, Richard, Villa, Diego, Goktepe, Ozge, Steidl, Christian, Slack, Graham W., Gascoyne, Randy D., Connors, Joseph M., Sehn, Laurie H.

    Published in Blood (16-11-2012)
    “…Abstract 303▪▪This icon denotes a clinically relevant abstract Primary mediastinal large B-cell lymphoma (PMBCL) was distinguished from DLBCL in the REAL/WHO…”
    Get full text
    Journal Article